Tender detail

Non-exclusive discount agreement for Guselkumab 100 mg medicine

Summary

DAK-Gesundheit is seeking a non-exclusive medicine discount agreement for the active ingredient guselkumab, limited to the 100 mg strength (ATC L04AC16). The agreement will run from 1 December 2026 to 31 March 2027, or end earlier if an exclusive agreement takes effect.

Reference number
c35f44bb-98c9-4551-b84a-bf5a9d85aef0
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2027-02-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.